Abstract
Since the last international conference on urolithiasis in 1984, citrate has received increasing recognition as an important pathogenetic factor in stone formation and as a therapeutic agent in the prevention of recurrent nephrolithiasis. Since other speakers will have covered pathophysiology of hypocitraturia and clinical response to citrate therapy, I shall consider the following topics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
JJ Meyer and LH Smith, Invest. Urol. 13: 36 (1975).
CYC Pak, MJ Nicar, and C Northcutt, in: “Contributions to Nephrology”, GM Berlyne, S Giovanetti, and S Thomas, eds., Karger, Basel, 33: 136 (1982).
MJ Nicar, K Hill, and CYC Pak, J. Bone Min. Res. 2: 215 (1987).
DJ Kok, SE Papapoulos, and OLM Bijvoet, The Lancet May 10: 1056 (1986).
CYC Pak and R Peterson, Arch. Int. Med. 146: 863 (1986).
CYC Pak, Min. Elec. Metab. 13: 257 (1987).
CYC Pak, J. Urol. 140: 461 (1988).
CYC Pak, K Sakhaee, and C Fuller, Kidney Int. 30: 422 (1986).
JG Gregory, KY Park, R Wilt, and A Geigl, in: “Urolithiasis: Clinical and Basic Research”, LH Smith, WG Robertson, and B Finlayson, eds., Plenum Press, New York (1981).
M Butz and HJ Dulce, in: “Urolithiasis: Clinical and Basic Research”, LH Smith, WG Robertson, and B Finlayson, eds., Plenum Press, New York (1981).
PO Schwille, G Rumenapf, H Schwarzlander, P Kuch, and H Berens, in: “Inhibitors of Crystallization in Renal Lithiasis and Their Clinical Application”, A Martelli, P Buli, and B Marchesini, eds., Acta Medica, Rome (1987).
J Lutz, Am. J. Clin. Nutr. 39: 281 (1984).
MJ Nicar, MC Hsu, and C Fetner, Clin. Therapeutics 8: 219 (1986).
K Sakhaee, M Nicar, K Hill, and CYC Pak, Kidney Int. 24: 348 (1983).
GM Preminger, K Sakhaee, and CYC Pak, J. Urol. 139: 240 (1988).
CYC Pak and C Fuller, Ann. Intern. Med. 104: 33 (1986).
GM Preminger, K Sakhaee, and CYC Pak, Metabolism 36: 176 (1987).
CYC Pak, JA Harvey, and MC Hsu, J. Clin. Endocrinol. Metab. 65: 801 (1987).
RR Recker, NEJM 313: 70 (1985).
J Lemann, JA Pleuss, and RW Gray, in: “Abstracts”, The American Soc. of Nephrology 19th Annual Meeting, Dec. 7–10, 1986.
DA Bushinsky, Am. J. Physiol. 254: F306 (1988).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pak, C.Y.C. (1989). Physicochemical Action and Extrarenal Manifestations of Alkali Therapy. In: Walker, V.R., Sutton, R.A.L., Cameron, E.C.B., Pak, C.Y.C., Robertson, W.G. (eds) Urolithiasis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0873-5_160
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0873-5_160
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0875-9
Online ISBN: 978-1-4899-0873-5
eBook Packages: Springer Book Archive